Genetic Testing Forum: Pharmacogenomics


Mayo Medical Laboratories' Genetic Testing Forum, Pharmacogenomics. This forum was be held August 11, 2015.

This presentation is about the current and future state of pharmacogenomics, and will include general information as a primer before progressing to specific testing offered by Mayo Clinic’s Personalized Genomics Laboratory. Problems surrounding reimbursement, data complexity, and reporting are also discussed. The central role of the genetic counselor is reviewed.


  • Participants will understand pharmacogenomic testing to include present and future testing methodologies and tests commonly ordered for patients requiring commonly used drugs (i.e. warfarin, tamoxifen, clopidogrel, codeine and others).
  • Participants will learn about the complexities of pharmacogenomics report generation and variant interpretation.
  • Participants will be exposed to the future landscape of pharmacogenomic testing.


Ann Moyer, M.D., Ph.D.

Ann Moyer, M.D., Ph.D.
Molecular Genetic Pathology Fellow
Mayo Clinic, Rochester, Minnesota

Ann Moyer is a Molecular Genetic Pathology Fellow in the Department of Laboratory Medicine and Pathology. She completed her undergraduate degrees at the University of Wisconsin-Platteville in both biology and chemistry prior to entering the Mayo Clinic Medical Scientist Training Program where she earned both her MD and PhD degrees. Her thesis work, which focused on pharmacogenomics of phase II drug metabolizing enzymes, was performed under the mentorship of Dr. Richard Weinshilboum. She then completed her Anatomic and Clinical Pathology residency training at Mayo Clinic with an additional year dedicated to research.

Michelle Kluge, M.S., CGC

Michelle Kluge, M.S., CGC
Personalized Genomics Laboratory
Mayo Clinic, Rochester, Minnesota

Michelle Kluge is a laboratory genetic counselor in the Mayo Clinic Department of Laboratory Medicine and Pathology. She earned her Master’s degree in genetic counseling from the University of Michigan and is board certified by the American Board of Genetic Counseling. She supports molecular genetic testing in both the Personalized Genomics and Endocrine Laboratories. Through her role in the Personalized Genomics Laboratory, Michelle provides support for pharmacogenomics testing performed at Mayo Clinic in Rochester, MN.


The genetics forums are applicable to geneticists and physicians, genetic counselors, laboratory directors and staff, nurses, and scientists.

The Genetic Testing Forum series is presented as an interactive audio and Web conference. Participants will receive an e-mail prior to each program which will contain a link to download the instructions for viewing the program. This link will also include the presentation handout. The presentation may also be viewed via Level 3 Communications Live Meeting technology. Level 3 Communications requires Internet Explorer 5.0 or higher.

There is no registration fee to participate. Note: Registration is no longer available.


Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.